Cargando…
Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340250/ http://dx.doi.org/10.1186/1748-7161-10-S1-O58 |
| _version_ | 1782359000568823808 |
|---|---|
| author | Yong, Mostyn RNO Savi, Flavia M Woodruff, Maria A Saifzadeh, Siamak Askin, Geoffrey N Labrom, Robert D Hutmacher, Dietmar W Adam, Clayton J |
| author_facet | Yong, Mostyn RNO Savi, Flavia M Woodruff, Maria A Saifzadeh, Siamak Askin, Geoffrey N Labrom, Robert D Hutmacher, Dietmar W Adam, Clayton J |
| author_sort | Yong, Mostyn RNO |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4340250 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43402502015-03-25 Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months Yong, Mostyn RNO Savi, Flavia M Woodruff, Maria A Saifzadeh, Siamak Askin, Geoffrey N Labrom, Robert D Hutmacher, Dietmar W Adam, Clayton J Scoliosis Oral Presentation BioMed Central 2015-01-19 /pmc/articles/PMC4340250/ http://dx.doi.org/10.1186/1748-7161-10-S1-O58 Text en Copyright © 2015 Yong et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Yong, Mostyn RNO Savi, Flavia M Woodruff, Maria A Saifzadeh, Siamak Askin, Geoffrey N Labrom, Robert D Hutmacher, Dietmar W Adam, Clayton J Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months |
| title | Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months |
| title_full | Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months |
| title_fullStr | Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months |
| title_full_unstemmed | Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months |
| title_short | Longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in large preclinical animal model: 6- versus 12 months |
| title_sort | longitudinal performance of polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhbmp-2) in large preclinical animal model: 6- versus 12 months |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340250/ http://dx.doi.org/10.1186/1748-7161-10-S1-O58 |
| work_keys_str_mv | AT yongmostynrno longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months AT saviflaviam longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months AT woodruffmariaa longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months AT saifzadehsiamak longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months AT askingeoffreyn longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months AT labromrobertd longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months AT hutmacherdietmarw longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months AT adamclaytonj longitudinalperformanceofpolycaprolactonebasedscaffoldplusrecombinanthumanmorphogeneticprotein2rhbmp2inlargepreclinicalanimalmodel6versus12months |